We are live on ! Find out more
Name Net increased
positions
Increased positions Reduced positions Return since
31 Dec ‘21
301
16 22 6 20.4%
302
16 32 16 120%
303
16 27 11 43.2%
LYEL icon
304
Lyell Immunopharma
LYEL
$287M
16 27 11 92%
305
16 26 10 14.2%
306
16 17 1 36.4%
307
16 88 72 17.7%
308
16 35 19 45%
309
16 24 8 18.4%
310
16 32 16 28.3%
GEVO icon
311
Gevo
GEVO
$385M
16 45 29 63.1%
312
16 24 8 12.6%
313
16 25 9 5.97%
314
16 65 49 85.2%
315
16 111 95 41.6%
316
16 24 8 21.8%
317
16 38 22 9%
318
16 41 25 30.5%
319
16 45 29 26.4%
320
16 24 8 7.58%
321
16 23 7 59.1%
322
16 27 11 29%
323
16 27 11 27.6%
324
16 113 97 82.7%
325
16 128 112 72.7%